Znn3bq.jpeg
²é¿´: 811  |  »Ø¸´: 5
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

¹Å¿É¤×

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

[½»Á÷] FDAÅú×¼Spectral Diagnostics ¹«Ë¾¸Ä±ä¸Ã¹«Ë¾ToÖÎÁƸÐȾÐÔÐݿ˵ĺóÆÚÁÙ´²ÊÔÑé·½°¸ ÒÑÓÐ5È˲ÎÓë

Ô­ÎÄÁ´½Ó£ºhttp://www.reuters.com/article/2 ... ntent=Google+Reader
·­ÒëµÄ²»ºÃ£¬»¹Íû¾ÀÕýºÍº£º­£¬¹²Í¬Ìá¸ß

Spectral Diagnostics Inc said the U.S. health regulator approved a change in the design of a late-stage trial of its therapy for septic shock, to increase the study's ability to detect the treatment's effects.
Spectral Diagnostics£¨¹âÆ×Õï¶Ï£©¹«Ë¾±íʾ£¬ÃÀ¹úÎÀÉú¼à¹Ü»ú¹¹Åú×¼¸Ã¹«Ë¾ÖÎÁƸÐȾÐÔÐݿ˺óÆÚÁÙ´²ÊÔÑéÉè¼Æ·½°¸µÄ±ä¸ü£¬ÒÔÌá¸ßÁÙ´²Ñо¿Ë®Æ½´Ó¶ø½ÒʾÁÙ´²ÁÆÐ§¡£

The trial, named EUPHRATES, will now have two interim analyses instead of one.
¸ÃÁÙ´²ÊÔÑé³ÆÎªEUPHRATES£¬½«½øÐÐÁ½ÏîÁÙ´²ÖÐÆÚ·ÖÎö£¬¶ø·ÇÒ»Ïî¡£

It tests the company's Toraymyxin, which has been approved for therapeutic use in Japan and Europe, combined with the standard of care.
´ËÁÙ´²ÊÔÑéΪ½øÐиù«Ë¾ToraymyxinµÄÁÙ´²Ñо¿£¬¸ÃÒ©ÔÚÈÕ±¾ºÍÅ·ÖÞÒѾ­±»Åú×¼ÓÃÓÚÖÎÁƸÐȾÐÔÐݿˣ¬²¢½áºÏ±ê×¼»¤Àí½øÐÐÖÎÁÆ¡£

The company expects the trial to be fully enrolled by the end of 2014.
¸Ã¹«Ë¾Ô¤¼Æ2014ÄêÄêµ×½«Íê³ÉÁÙ´²ÊÔÑéÈ«²¿²¡ÀýµÄÈë×é¡£

Septic shock is a potentially dangerous fall in blood pressure because of the presence of bacteria.ÒòÓÐϸ¾ú´æÔÚ£¬¸ÐȾÐÔÐÝ¿ËÊÇѪѹϽµµÄDZÔÚ·çÏÕÒòËØ¡£

Based on the current rate of enrolment, Spectral will disclose results of the first analysis before the end of the first quarter of 2013, it said in a statement.
Ôڸù«Ë¾Ò»·ÝÉùÃ÷ÖУ¬»ùÓÚĿǰÁÙ´²ÊÔÑéµÄÈë×éÂÊ£¬¸Ã¹«Ë¾½«ÔÚ2013ÄêµÚÒ»¼¾¶Èǰ¹«²¼µÚÒ»ÆÚÁÙ´²ÊÔÑéµÄ·ÖÎö½á¹û£¬

Shares of the company closed at 24.5 Canadian cents on Tuesday on the Toronto Stock Exchange. ±¾Öܶþ£¬¸Ã¹«Ë¾¹É¼ÛÔÚ¶àÂ×¶à֤ȯ½»Ò×ËùµÄÊÕÅ̼ÛΪ24.5¼ÓԪÿ¹É¡£

[ Last edited by ¹Å¿É¤× on 2012-10-19 at 16:52 ]
»Ø¸´´ËÂ¥

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

·ÇÎáСÌìÏ£¬²Å¸ß¶øÒÑ£»·ÇÎá×ݹŽñ£¬Ê±¸³¶øÒÑ£»·ÇÎáíþ¾ÅÖÝ£¬ºê¹Û¶øÒÑ£»Èý·ÇÑÉ×ÎÞÃÎÖÁʤ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xunmeng1985

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¹ÅÇøÐÁ¿à£¡
̤ѩѰ÷£¬°Ù»¨Éî´¦£¡
6Â¥2012-10-20 12:25:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 6 ¸ö»Ø´ð

okitworks

ľ³æ (ÖøÃûдÊÖ)

ÓÅÐã°æÖ÷

Êׯª¿ÆÑпìѶ£¬ÆÄÊÜÆô·¢¡£
5Â¥2012-10-20 09:12:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á +10 СȽҪŬÁ¦ 2026-04-10 11/550 2026-04-13 09:34 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] ÉúÎïѧ308Çóµ÷¼Á +5 ÏàÐűػá¹ââÍòÕ 2026-04-11 5/250 2026-04-12 18:14 by zhouxiaoyu
[¿¼ÑÐ] µ÷¼Á +25 ²»·ê´º 2026-04-07 26/1300 2026-04-12 11:53 by ´óÁ¦Ë®ÊÖÁ¦´óÎÞÇ
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ289 085602 +33 yangæÃ 2026-04-10 34/1700 2026-04-12 08:11 by Art1977
[¿¼ÑÐ] 312Çóµ÷¼Á +6 Àîºè·É·É 2026-04-06 6/300 2026-04-12 00:34 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 280Çóµ÷¼Á +7 ÙâÙâÒ¹Ò¹ 2026-04-09 10/500 2026-04-12 00:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] »¯¹¤µ÷¼ÁÇóµ¼Ê¦ÊÕÁô£¡Ò»Ö¾Ô¸Ê§Àû£¬Ì¤Êµ¿Ï¸É£¬ÓÐÖ²ÎïÌáÈ¡¿ÆÑо­Àú +20 yzyzx 2026-04-09 21/1050 2026-04-12 00:12 by ССССÀ²À²À²
[¿¼ÑÐ] 359Çóµ÷¼Á +5 θ¾·ÂÎÀÛÁË 2026-04-11 5/250 2026-04-11 19:55 by lbsjt
[¿¼ÑÐ] µ÷¼Á +5 ÎĵÀÐÇ̨ 2026-04-11 5/250 2026-04-11 15:01 by ¿­¿­Òª±ä˧
[¿¼ÑÐ] ±¾ÈËÅ®º¢ +7 ºðºð£¬ 2026-04-10 9/450 2026-04-11 14:45 by ACS Nano¡ª¡ª
[¿¼ÑÐ] Çóµ÷¼Á +3 θ¾·ÂÎÀÛÁË 2026-04-11 5/250 2026-04-11 14:13 by luhong1990
[¿¼ÑÐ] 085402ͨÐŹ¤³Ìµ÷¼Á£¬ÓÐ4Ïîѧ¿Æ¾ºÈü¹ú½±£¨µçÈü¹ú¶þ£©£¬Ë¶Ê¿Ñо¿Éúµ÷¼Á×Ô¼öÐÅ¡£ +5 mÓÀo²»vÑÔoÆúm 2026-04-09 5/250 2026-04-11 09:33 by zhq0425
[¿¼ÑÐ] 265Çóµ÷¼Á +12 ·ç˵ËýÔçÍüÁË 2026-04-10 13/650 2026-04-10 18:56 by chemisry
[¿¼ÑÐ] 314Çóµ÷¼Á +18 xhhdjdjsjks 2026-04-09 19/950 2026-04-10 18:53 by HPUCZ
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +27 ŬÁ¦·Ü¶·112 2026-04-07 30/1500 2026-04-10 15:06 by Kilig0317
[¿¼ÑÐ] һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á +20 Ľ¾øcc 2026-04-09 24/1200 2026-04-10 10:22 by xujun0624
[¿¼ÑÐ] 311Çóµ÷¼Á +6 surte 2026-04-08 13/650 2026-04-09 14:00 by surte
[¿¼ÑÐ] 265Çóµ÷¼Á +4 ·ç˵ËýÔçÍüÁË 2026-04-07 4/200 2026-04-09 13:59 by onlyÖÜ
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +13 ºº123456 2026-04-07 14/700 2026-04-07 22:53 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] »úеµ÷¼Á +3 zzzbcb 2026-04-07 3/150 2026-04-07 22:19 by hemengdong
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û